Followers | 416 |
Posts | 34739 |
Boards Moderated | 1 |
Alias Born | 08/22/2004 |
Tuesday, July 20, 2021 10:02:01 AM
Given the near-term potential for a resurgence of COVID-19 infections driven by emerging variants, Immunome intends to explore opportunities to expedite the development of this potential therapeutic. The Company plans to submit an IND application with the U.S. Food and Drug Administration (FDA) this quarter.
Recent IMNM News
- Immunome Appoints Phil Tsai as Chief Technical Officer • Business Wire • 06/27/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/19/2024 01:08:29 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/19/2024 01:05:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/19/2024 01:01:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/19/2024 12:56:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/19/2024 12:48:32 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:05:42 PM
- Immunome Announces Completion of Purchase of Assets from Atreca • Business Wire • 05/20/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:11:18 PM
- Immunome Announces Promotion of Max Rosett to Chief Financial Officer • Business Wire • 05/17/2024 12:00:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/14/2024 12:48:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 12:05:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 12:02:25 PM
- Immunome Reports First Quarter 2024 Financial Results and Provides Business Update • Business Wire • 05/14/2024 12:00:00 PM
- Immunome to Present at 2024 Bank of America Healthcare Conference • Business Wire • 05/08/2024 12:00:00 PM
- Immunome Appoints Kinney Horn as Chief Business Officer • Business Wire • 05/02/2024 12:00:00 PM
- Immunome Appoints Sandra M. Swain to Board of Directors • Business Wire • 04/25/2024 12:26:00 PM
- Immunome to Present Preclinical Data for IM-3050, Its Lead Radioligand Therapy Candidate, at 2024 American Association for Cancer Research (AACR) Annual Meeting • Business Wire • 04/05/2024 12:00:00 PM
- Immunome Reports Full Year 2023 Financial Results and Provides Update on Recently Acquired Assets • Business Wire • 03/28/2024 08:02:00 PM
- Immunome Completes Acquisition of AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala • Business Wire • 03/26/2024 12:00:00 PM
- Immunome to Participate in the Leerink Partners Global Biopharma Conference • Business Wire • 03/07/2024 01:00:00 PM
- Immunome to Participate in the TD Cowen 44th Annual Healthcare Conference • Business Wire • 03/01/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:10:50 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:07:36 AM
- Immunome Recognizes Ayala Pharmaceuticals’ Announced Completion of Enrollment in Phase 3 RINGSIDE Study Evaluating AL102 in Desmoid Tumors • Business Wire • 02/20/2024 01:15:00 PM
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM